Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	1,793	1,096	152	63	783	3,940	Upgrade
Market Cap Growth	129.01%	621.31%	140.03%	-91.91%	-80.13%	-	Upgrade
Enterprise Value	1,384	834	-73	-350	165	4,503	Upgrade
PE Ratio	36.93	37.54	-	-	-	-	Upgrade
PS Ratio	1.38	0.93	0.33	0.20	2.27	11.36	Upgrade
PB Ratio	7.76	3.47	0.55	0.16	1.21	3.82	Upgrade
P/FCF Ratio	8.63	5.61	-	-	-	-	Upgrade
P/OCF Ratio	8.62	5.60	-	-	-	-	Upgrade
EV/Sales Ratio	1.09	0.71	-	-	0.48	12.98	Upgrade
EV/EBITDA Ratio	13.57	9.86	-	-	-	-	Upgrade
EV/EBIT Ratio	14.28	10.60	-	-	-	-	Upgrade
EV/FCF Ratio	6.66	4.27	-	-	-	-	Upgrade
Debt / Equity Ratio	0.59	0.65	1.11	0.79	0.02	0.18	Upgrade
Debt / EBITDA Ratio	1.93	2.39	-	-	-	-	Upgrade
Debt / FCF Ratio	0.96	1.06	-	-	-	-	Upgrade
Quick Ratio	1.94	2.00	2.30	2.95	2.75	4.24	Upgrade
Current Ratio	2.30	2.38	2.73	3.71	3.57	5.05	Upgrade
Asset Turnover	0.84	0.83	0.34	0.24	0.22	0.28	Upgrade
Return on Equity (ROE)	17.95%	10.42%	-44.21%	-57.39%	-62.01%	-59.57%	Upgrade
Return on Assets (ROA)	4.01%	3.46%	-4.23%	-11.61%	-19.68%	-14.32%	Upgrade
Return on Capital (ROIC)	10.84%	8.89%	-8.80%	-22.51%	-32.21%	-22.30%	Upgrade
Earnings Yield	2.95%	2.66%	-97.00%	-470.23%	-66.57%	-9.21%	Upgrade
Earnings Yield	2.95%	2.66%	-97.00%	-470.23%	-66.57%	-9.21%	Upgrade
FCF Yield	11.59%	17.82%	-22.24%	-332.65%	-52.12%	-7.33%	Upgrade
Buyback Yield / Dilution	-21.03%	-17.36%	-2.13%	-2.17%	-228.57%	-123.01%	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.

SEC Filings: 10-K · 10-Q